Any PK PD article with 🌟 Jason Roberts is a must-read 🆕️🔥Systematic review #JAC Getnet M Assefa Fekade B Sime What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? #IDXposts academic.oup.com/jac/article/do…

I am excited to share our recent publication on PK/PD targets of B-lactamase inhibitors. I would like to extend my greatful appreciation to my supervisors Fekade B Sime and Jason Roberts for their contribution. academic.oup.com/jac/advance-ar…

Our annual magazine, UQ Medicine has featured an article about the contributions of The Centre for Clinical Research #UQCCR over the years. stories.uq.edu.au/medicine/2023/…

Pls retweet : We are looking for a postdoctoral fellow with experience in formulation design and antimicrobial testing - come join us UQ Pharmacy Institute for Molecular Bioscience Mark Blaskovich Drug Delivery Australia Young Scientist Committee YSC-CRS apply below 👇 seek.com.au/job/74760321

Great to see this - Evaluation of stability of ceftazidime/avibactam in elastomeric infusion devices used for OPAT. 🇬🇧 & 🇦🇺 partnership in this space continues ⁦⁦Fekade B Sime⁩ ⁦Jason Roberts⁩ ⁦andrew seaton⁩ ⁦@jamiesonce⁩ & more academic.oup.com/jacamr/article…

Risk scoring tools for early prediction of CRE BSIs have limitations and lack of external validity outside the local setting in which they were developed: doi.org/10.1093/jacamr… @OUPMedicine Oxford Journals #JACAMRNews

Congratulations 🎆🎆 Saiyuri Naicker

Well done Mikaela, excellent talk!

🆕️🔥State of the art review article #JAC 🌟s Jason Roberts Fekade B Sime Mark Gilchrist Current Practices and challenges of outpatient parenteral antimicrobial therapy #OPAT #IDXposts #bookmark Great tables🎯 academic.oup.com/jac/article/do…

🌟NEW in IJAA🌟 Authors find #OPAT is a safe and effective alternative to inpatient IV #antimicrobial treatment in this systematic review & meta-analysis which includes >1,300 patients. Read the open access article⬇️ tinyurl.com/43jmdc3c

SO excited to officially announce the 2024 Pharmacy to Dose Award winners! 🎉 🍾 Research article of the year: Jason Roberts Jason Roberts Non-research article of the year : Mojdeh Heavner @HeavnerPharmD Preceptor of the Year: Grace Benanti Mentor of the Year: Brian

Our article: doi.org/10.1093/jac/dk…… has been selected for inclusion in the Best of Journal of Antimicrobial Chemotherapy 2024. Fekade B Sime Jason Roberts CRE RESPOND #UQCCR UQ Medicine UQ News academic.oup.com/jac/pages/best…

#UQCCR Publication of the Month Winner for December 👏 Congratulations Getnet M Assefa 🎊 UQ Medicine UQ News

💥 BIG problems need BIG solutions Drug resistance is putting lives at risk worldwide. That’s why we’re launching #ThisIsBig—a bold campaign calling for greater investment and collaboration to develop new antibiotics and expand access to treatment 🚀 📢 Share the video.

Honoured to receive the HDR Award Winner recognition at the Herston Health Precinct Symposium 2025. I am grateful to my supervisors, Fekade B Sime and Jason Roberts, for their invaluable support. #HHPS2025, CRE RESPOND, #UQCCR, UQ Medicine, UQ News

🤩The third instalment of the CRE RESPOND quarterly newsletter will be sent out tomorrow!🤩 📣 Our newsletter lets you stay informed on our talented and dedicated team of researchers and their current projects and publications, as well as our visitors who come from all over the

New RCT from UQ Medicine Cefiderocol versus standard therapy for healthcare-associated Gram-negative BSI GAME CHANGER Trial UQ News >500 patients in 6 countries with high rates of MDR; 25% carb-R; Non-inferior but not superior for 14d mortality The Lancet Infectious Diseases David Paterson

Super interesting! 🆕💫Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa #idxposts The punch effect! academic.oup.com/jac/article-ab…

🙌We are proud to introduce CRE RESPOND's final seminar of the year as part of the Education Program 2025!🙌 We're thrilled to announce that the UTI Guidelines: Clinical practice guidelines on prevention and management of Urinary Tract Infections (UTIs) seminar will take place

Super interesting! 🆕💫Keeping the horse *with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales #IDXposts journals.asm.org/doi/10.1128/aa…